Although up to 82% of plans cover GLP-1 medications for diabetes, 1% or less cover GLP-1 drugs for obesity, such as Saxenda, Wegovy, and Zepbound. Written by Veronica Salib #glp1 #obesity #diabetes https://lnkd.in/ec7Jhbnr
PharmaNewsIntelligence’s Post
More Relevant Posts
-
📍 By now, it is pretty clear that the new weight loss and diabetes medications have achieved blockbuster status. #Semaglutide (sold as #Ozempic for diabetes and #Wegovy for weight loss) and #tirzepatide (sold as #Mounjaro for diabetes and #Zepbound for weight loss) work by mimicking one or more naturally occurring hormones — including glucagon-like peptide-1 — that operate in several ways: They increase insulin production, slow our digestion (so we feel full longer) and signal the brain to stop eating because we are satiated. Unlike previous weight loss medications, they are pretty effective at helping people lose weight and keep it off — between around 15% to 20% of body weight — with relatively few side effects (although some people can’t tolerate them, and a fraction of patients experience more severe side effects). As a result, demand for semaglutide and tirzepatide is high. During the last three months of 2022 alone, US health care providers wrote more than 9 million prescriptions for these and similar medications, according to a report from analytics firm Trilliant Health. The same analysis found quarterly prescriptions ballooned 300% between the start of 2020 and the end of 2022. 🔹These drugs are not right for everyone For many people, the cultural pressure to look a certain way is high. “Not everyone who wants these drugs should necessarily be on them, and not everyone who technically qualifies to take them will want to,” Tirrell said. “With medicines for weight loss, physical appearance can get tangled up in external perceptions of health — but whether to take any medicine is a personal decision, made in consultation with a doctor.” Unfortunately, supply has not kept up with the soaring popularity. Some people have resorted to ordering the drugs online or through compounding pharmacies, both of which can be a gamble. In other countries, fake versions have led to hospitalizations. The market is only expected to grow: A Goldman Sachs report projected 13% of US adults — roughly 15 million people — might be on one of these medications for weight loss by 2030. Insurance coverage can be difficult Thesea weight loss #medicines #cost about $1,000 a month or more out of pocket, and many employers, as well as Medicare, don’t cover them. ➡️ https://lnkd.in/eabgYGyQ #weightloss #weightlossjourney #ozempic #glp1 #wegovy #weightlossdrugs
How to access the new weight loss drugs | CNN
amp.cnn.com
To view or add a comment, sign in
-
Exciting to see Vida Health mentioned in Reuters today along with several of our esteemed partners! We're all working together to provide clinically appropriate ways to improve outcomes in obesity--and helping clients do so in a sustainable way. I've said it before: these new miracle weight loss drugs are not for everyone. They can provide amazing results for those who have tried other methods that haven't worked for them. Medicine has an important place in clinical practice, and we all hope these drugs will become more affordable with time. But GLP-1 and tirzepatide injectables are still expensive. They are neither clinically appropriate nor affordable for everyone who wants them. For many patients, there are safe, affordable, and effective alternatives. That's why at Vida, we work with clients to provide all the options that fit their holistic obesity strategy--not just one limited tool.
Plenty of solutions are coming to market right now in an attempt to capitalize on renewed interest in #obesity. Some of these open the floodgates to expensive #GLP1s while others take a strict anti-medication stance and focus solely on diet or behavior change. But there’s a more nuanced and clinically rigorous approach that curbs costs and drives meaningful results: obesity step therapy. Thanks to Reuters for including a number of our clients and Vida Health in this piece on how solutions like ours are making a difference for employers. #weightloss #glp1 #Wegovy
US employers hire virtual providers as weight-loss drug gatekeepers
reuters.com
To view or add a comment, sign in
-
Plenty of solutions are coming to market right now in an attempt to capitalize on renewed interest in #obesity. Some of these open the floodgates to expensive #GLP1s while others take a strict anti-medication stance and focus solely on diet or behavior change. But there’s a more nuanced and clinically rigorous approach that curbs costs and drives meaningful results: obesity step therapy. Thanks to Reuters for including a number of our clients and Vida Health in this piece on how solutions like ours are making a difference for employers. #weightloss #glp1 #Wegovy
US employers hire virtual providers as weight-loss drug gatekeepers
reuters.com
To view or add a comment, sign in
-
The honeymoon period may be over for Ozempic and drugs like it, as they are increasingly linked to gastrointestinal side effects, some of them requiring hospitalization. Covering GLP-1s under #MedicarePartD for authorized uses is already making a mark on total Part D program costs and could be a sign of even higher spending to come! We need to address the real cause of obesity which is our toxic food supply. https://lnkd.in/ePVsWB46
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing | KFF
https://www.kff.org
To view or add a comment, sign in
-
Don’t forget Topicals Hi, I have chronic neck and referred shoulder pain. Chronic migraines and C5, C6 nerve damage. I know because I just had an EMG. Caused a lot of pain for 5 days but directly verified what I feel every day. If you have chronic pain and take medication, don’t forget topical medicines can help. I know there was a focus on them at the early years of the cannabis dispensaries in Md when I was going, but now it seems the push is on higher and higher levels of cannabis products, meaning %THC. For example, yesterday I was in a lot of pain. I noticed the pain medication I take wasn’t especially effective after a given dose. I was laying down with the heating pad on my neck and shoulders as usual thinking about what else I could do. I decided to sort through a cabinet I have to see if I had anything left. Turns out I had a prescription gel from a past provider (check date to make sure medication is not expired). I put this on. Actually, it provided deep relief! I’m so glad I kept it and found it. Now I can ask current provider for it. Ask your provider if topical treatments may help you. Sometimes lidocaine patches available over the counter are helpful. Usually the professional formulation is not covered by insurance unless you have diabetes. I just tried this, and the patches were $120! I will opt for the over the counter version because of price. The gel I used was Diclofenac Sodium Gel, 3% (NSAID Warnings). Hope you get as good results as I have!
To view or add a comment, sign in
-
Over the past year, weight loss drugs have dominated the news and public discourse. Originally developed to treat diabetes, medicines like Ozempic and Wegovy have become popularly known as obesity drugs. As their popularity grows, these drugs are expected to generate over $100 billion by 2030. However, their high cost and limited insurance coverage present challenges for employers and plan sponsors in managing access and containing costs. Learn more about the GLP-1 market's growth and explore strategies for effective cost management from Jill Ambrose, Partner, Director, Population Health and Daniel P. Keenan, Vice President, Business Development Executive: https://hubs.la/Q02yQ1v40
GLP-1s: The New Era of Weight Management - Conner Strong
https://www.connerstrong.com
To view or add a comment, sign in
-
The honeymoon period may be over for Ozempic and drugs like it, as they are increasingly linked to gastrointestinal side effects, some of them requiring hospitalization. Covering GLP-1s under #MedicarePartD for authorized uses is already making a mark on total Part D program costs and could be a sign of even higher spending to come! We need to address the real cause of obesity which is our toxic food supply.
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing | KFF
https://www.kff.org
To view or add a comment, sign in
-
🎉 Big News in the Pharma World! 🎉 Eli Lilly and Company groundbreaking obesity treatment, #Zepbound, is now hitting U.S. pharmacy shelves! Priced at $550/month for those without insurance coverage. Approved last November, #zepbound is a powerful alternative to Novo Nordisk ,and comes with a sweet deal: With insurance, it could cost as little as $25! Already causing a buzz, Eli Lilly and Company shares have soared 60% this year. Here's to a healthier future!💊🚀 #pharmanews #weightloss #drugdevelopment #obesitytreatment https://lnkd.in/g6DYpsds
Eli Lilly obesity drug now available in US pharmacies
reuters.com
To view or add a comment, sign in
-
(NEWSMAX HLTH.) - "What to Know about Eli Lilly's New Obesity Drug." The U.S. Food and Drug Administration approved Eli Lilly's keenly-awaited obesity treatment on Wednesday, introducing a powerful rival to Novo Nordisk's popular weight-loss therapy Wegovy. Finally AFFORDABLE Health Insurance Plans At: HI4E.org #Wegovy #Ozempic #Tirzepatide #AffordableDrugs #WeightLossDrugTirzepatide #FatBodies #WeightLossDrugs #Obesity #EliLillyWeightLossDrug #WeightLossShot #ObesityDrugs #WeightLossInjections #MedicareObesityDrugs #BrainPowerWithWeightLoss #WeightControl #ObesityInflammatoryResponses #HI4E.Org #HealthAndLifeSolutionsLLC #FitnessGoals #WeightControlAidsBrainHealth #OverweightPeople #WeightLoss #CalorieCounting #Obesity #OverweightAdults #PharmacyBenefitManagers #HealthyLivingTips #WeightWatchers #HealthInsuranceForEveryone #NewsmaxHlth #DrugsPriceList
What to Know about Eli Lilly's New Obesity Drug
newsmax.com
To view or add a comment, sign in
-
*independent community retail pharmacy*helping independent pharmacies integrate innovative products and practices to drive additional revenue* helping start wellness businesses globally
It is still hard for many patients to get the weight loss shots. It is even harder (basically impossible) for independent pharmacies to make any profit from dispensing them. There are also some that prefer an all natural supplement rather than a weekly injection. If you have patients that want to lose weight but will not (or cannot) use the weight loss shots, there is a GREAT, all natural supplement that many people are having success with, without the risks associated with the 💉💉💉. Or maybe it’s YOU. Maybe YOU are looking to balance cortisol and insulin levels and get healthier in 2024. Message me or comment below for more info⤵️ #weightloss #allnatural #hormonebalance #cortisolbalance #weightlosssuccess https://lnkd.in/gcVp9qhU
Getting hot new weight-loss drugs like Wegovy will still be a struggle in 2024
businessinsider.com
To view or add a comment, sign in